Sacutan 24/26 Tablets

₨ 370

In stock
Pack size14
FormTablet
Delivery in 2 to 3 working daysTo cities across Pakistan, delivery from ₨ 300
Cash on deliveryOr pay by bank transfer or card at checkout
Genuine productsFrom a DRAP-licensed pharmacy
Damaged or wrong item?We take it back. Read the return policy
Have a prescription? Upload it and our pharmacist will check your order.Questions about this product? WhatsApp 0336 3300001

About this product

Overview

SACUTAN 24/26 TABLETS is a medication that combines two active ingredients: sacubitril and valsartan. Sacubitril is a neprilysin inhibitor, and valsartan is an angiotensin II receptor blocker (ARB). This combination works synergistically to manage certain cardiovascular conditions.

Uses

  1. Heart Failure:
    • SACUTAN is indicated for the treatment of chronic heart failure (NYHA Class II-IV) in adults to reduce the risk of cardiovascular death and hospitalization.

Side Effects

Common side effects may include:

  • Hypotension (low blood pressure)
  • Elevated levels of potassium in the blood
  • Dizziness or lightheadedness
  • Cough
  • Kidney problems

Serious side effects may include:

  • Angioedema (swelling of the deeper layers of the skin)
  • Impaired renal function
  • Hypotension, especially in patients with volume depletion

When Not to Use

  1. Pregnancy:
    • SACUTAN is contraindicated in pregnancy. It can cause fetal harm, and women who become pregnant should discontinue the medication as soon as possible.
  2. Hypersensitivity:
    • Individuals with a history of hypersensitivity to sacubitril or valsartan should not use SACUTAN.
  3. Use with Aliskiren:
    • SACUTAN should not be co-administered with aliskiren in patients with diabetes due to the increased risk of renal impairment, hypotension, and hyperkalemia.
  4. Severe Hepatic Impairment:
    • SACUTAN is not recommended in patients with severe hepatic impairment.

Precautions and Warnings

  • Renal Impairment:
    • Monitoring of renal function is essential, especially in patients with renal impairment or those concomitantly taking other medications affecting the renin-angiotensin-aldosterone system.
  • Hypotension:
    • Patients may experience symptomatic hypotension, particularly after the first dose. Blood pressure should be monitored regularly.
  • Hyperkalemia:
    • Monitoring of potassium levels is advised, especially in patients at risk of hyperkalemia.

It is crucial to consult with a healthcare professional before starting or discontinuing SACUTAN, as individual patient circumstances may vary. This information is not exhaustive, and healthcare providers should refer to the prescribing information for a comprehensive understanding of the medication.

This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.

Customer reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Sacutan 24/26 Tablets”